Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 Exhibit 3.1
- 4.1 Exhibit 4.1
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 10.14 Exhibit 10.14
- 10.15 Exhibit 10.15
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
Associated filings
- 11 Dec 20 424B4 Prospectus supplement with pricing info
- 11 Dec 20 FWP Free writing prospectus
- 11 Dec 20 EFFECT Notice of effectiveness
- 10 Dec 20 FWP Free writing prospectus
- 9 Dec 20 F-1/A Registration statement (foreign) (amended)
- 7 Dec 20 F-1/A Registration statement (foreign) (amended)
-
20 Nov 20 F-1 Registration statement (foreign)
NBTX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 5, 2020, in the Registration Statement (Form F-1) and related Prospectus of Nanobiotix S.A. dated November 20, 2020.
/s/ ERNST & YOUNG et Autres
Paris La Défense, France
November 20, 2020